SCHEMBL3479568

SCHEMBL3479568

CN1CCN(c2ccc3ccccc3c2F)c2ccc(-n3ccccc3=O)cc2C1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 1/20 0.40
SLC6A2 P23975 1/20 0.36
SLC6A4 P31645 1/20 0.36
SLC6A3 Q01959 1/20 0.36
SCN9A Q15858 1/20 0.35
CYP1A1 P04798 2/20 0.35
CYP1B1 Q16678 2/20 0.35
F10 P00742 3/20 0.34
HTR3A P46098 2/20 0.34
CYP1A2 P05177 1/20 0.32
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
GLA P06280 1/20 0.32
GAA P10253 1/20 0.32
CASP1 P29466 1/20 0.32
CASP7 P55210 1/20 0.32
HSD17B10 Q99714 1/20 0.32
HTR1A P08908 1/20 0.32
HTR1D P28221 1/20 0.32
HTR1B P28222 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3479718 0.85 HRH4 (0.40) HRH4SLC6A2SLC6A4SLC6A3SCN9A
SCHEMBL3479776 0.84 HRH3 (0.40) HRH4SLC6A2SLC6A4SLC6A3SCN9A
SCHEMBL3228568 0.84 HTR3A (0.46) HRH4SLC6A2SLC6A4SLC6A3SCN9A
SCHEMBL3479707 0.82 HRH4 (0.39) HRH4SLC6A2SLC6A4SLC6A3SCN9A
SCHEMBL3234584 0.82 HRH4 (0.41) HRH4SLC6A2SLC6A4SLC6A3SCN9A
SCHEMBL3479641 0.81 HRH4 (0.44) HRH4SLC6A2SLC6A4SLC6A3SCN9A
SCHEMBL3479624 0.81 HRH4 (0.41) HRH4SLC6A2SLC6A4SLC6A3SCN9A
SCHEMBL3225885 0.80 MAOA (0.39) HRH4SLC6A4HTR3AKDM4EHTR1A
SCHEMBL3235499 0.78 SLC6A2 (0.49) HRH4SLC6A2SLC6A4SLC6A3SCN9A
SCHEMBL3233165 0.78 ALDH1A1 (0.44) HRH4SCN9AKDM4EALDH1A1GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9096546-B2 Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin ALBANY MOLECULAR RESEARCH, INC. (US) 2015-08-04 US disclosed
US-20100137287-A1 ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN ALBANY MOLECULAR RESEARCH, INC. (US) 2010-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137287-A1 ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN ADRA1B, ADRB1, ADRA1D HRH4 90/4885SLC6A2 28/4885SLC6A4 40/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.